Article
Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.
Journal of pediatric hematology/oncology - 1 May 2008
Shimasaki Noriko, Mori Tetsuya, Torii Chiharu, Sato Reiko, Shimada Hiroyuki, Tanigawara Yusuke, Kosaki Kenjiro, Takahashi Takao
Abstract excerpt
We investigated preliminarily whether methylenetetrahydrofolate reductase (MTHFR) 677C/T or reduced folate carrier 1 (RFC1) 80G/A polymorphisms were associated with toxicities during maintenance chemotherapy with mercaptopurine (6MP) and methotrexate (MTX) in children with acute lymphoblastic leu...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
